Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine during ESD for Gastric Neoplasm
NCT02543411Completed
- Sponsor
- Severance Hospital
- Start
- Sep 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in gastric cancer (GC) (2 arms), sponsored by Severance Hospital. Primary endpoint: Fentanyl consumption during sedation. Started Sep 2015; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02543411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02543411.